META is developing glucoWISE®, a non-invasive, 100% pain-free device for the monitoring of blood glucose levels without the need to pierce the user’s skin that is a cost-effective alternative to traditional technologies. The system allows frequent monitoring of glucose levels that will decrease the risk of developing life-threatening conditions.
Primary Application Area: Healthcare & Medical Devices
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Organization Type: Small to Medium Enterprise
GOVT/EXTERNAL FUNDING SOURCES